Introduction
The Abortion Act 1967 affords mothers with a substantial risk of bearing a seriously handicapped child the choice of having the pregnancy terminated. Many such parents are now referred to genetic clinics for assessment of this risk. Even with a high risk-for example, in autosomal recessive disorders-the decision to terminate will result on average in the sacrifice of only of the pregnancies in which the fetus is affected.
The diagnosis of genetic defects in the fetus is possible by cytological and biochemical analysis of the amniotic fluid obtained by transabdominal amniocentesis. As chromosome aberrations are numerically the most important indication for antenatal diagnosis our efforts have been directed particularly at the chromosome analysis of cultured amniotic fluid cells (Ferguson-Smith and Ferguson-Smith, 1970) . This report describes our experience of 30 consecutive patients referred for genetic counselling during pregnancy.
Materials and Methods
Specimens of amniotic fluid from the 30 patients referred for antenatal diagnosis were obtained by transabdominal amniocentesis. In addition, amniotic cell cultures were attempted in 24 pregnancies terminated by hysterotomy and in one specimen of amniotic fluid obtained in late pregnancy because of rhesus incompatibility. In the therapeutic abortions the fluid was aspirated by syringe from the intact sac shortly after hysterotomy. Fifteen of the specimens for antenatal diagnosis were transported to Glasgow by air on the day of amniocentesis (B3, B19, B37, B41, B47, B58, B67, B68, B70, B71, B72, and B73 from Belfast; B25 and B65 from Oxford; and B46 from Manchester). One specimen (B60 from Newcastle) arrived the following day by rail, and one specimen (B75 from Oxford) arrived by post two days later.
In 39 of the 55 specimens 1-2 ml of the fluid was used also for sex chromatin analysis. An additional 30 specimens of amniotic fluid, obtained specifically for the evaluation of the sex chromatin test, have been included in the series. In all cases the sex chromatin status was determined before confirmation by chromosome analysis of cultured amniotic fluid cells, by chromosome analysis of fibroblast cultures from fetal biopsy material, or by subsequent examination of the child at birth.
Our culture technique, based on that of Nadler (1968) , has been modified by previous experience (Ferguson-Smith and Ferguson-Smith, 1970) . After allocating 1-2 ml of amniotic fluid for sex chromatin analysis, 10-15 ml in a sterile polystyrene container is centrifuged at 1,000 r.p.m. for 10 minutes. The supernatant is removed, leaving 1 ml in which to resuspend the cell (Danes and Beam, 1966 The results of amniotic cell culture in the 24 hysterotomies and in the case of amniocentesis for rhesus incompatibility are shown in Table II . Satisfactory growth of amniotic cells was obtained in 21 samples (84%) with karyotype analysis in 17 (68%). The problems connected with obtaining amniotic fluid from hysterotomy specimens probably account for the lower rate of successful chromosome analysis. However, unsuccessful samples were from conceptions at 7, 8, 10, 10, 10, 11, 15, and 32 weeks gestation. This confirms our observation in earlier studies (Ferguson-Smith and Ferguson-Smith, 1970) that amniotic specimens obtained before 14 weeks and possibly after 30 weeks are less satisfactory than specimens obtained at 14 to 30 weeks. This is probably related to the low cell count in early pregnancy and the large number of anucleate cells in later pregnancy (Votta et al., 1968; Wachtel et al., 1969) .
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One culture (B29) is of special interest as all mitoses were tetraploid. The occurrence of hign frequencies of tetraploid 17  10  15  19  18  15  14  18  18  30  33  17  16  13  15  20  17  17  17  22  16  15  17  16  16  16  16  17  21  15  17  16  26  16  18  24  16  14  16  16  14  13  14 A5   A8  A9  A10  A21  A27  A28   A30  A31  A32   A38  A40  A41  A43  A45  A51  A60  A64  BI  B3  B6  B8   B1O  Bl1   B13  B15  B17  B18  B19  B20  B21  B22  B25  B28  B31  B32  B33  B34  B36  B37  B38  B39  B40  B41  B42   B45   B46   B52  B54  B55  B57  B58  B59   B61   B62  B65  B67  B68  B69  B70  B71  B72  B73   B75   B76 1 cells in amniotic cell cultures from normal embryos is well recognized (Walker et al., 1970) , though the absence of any diploid cells after only 17 days in culture in our case mignt suggest that the embryo had been tetraploid from conception. We were unable to obtain further evidence on this point as tissue taken from the apparently normal fetus failed to grow in culture. The frequency of completely tetraploid embryos in early pregnancy must be low, judging from chromosome studies in spontaneous abortion (Carr, 1965) , which suggest a rate of about 1-5 per 1,000.
With this one exception, the cultures in the hysterotomy series had normal karyotypes.
ANALYSIS OF SEX CHROMATIN AND FLUORESCENT Y BODIES
The fetal sex was correctly diagnosed by sex chromatin analysis in the 66 cases examined (Table III) . In the female fetus 20 to 44% of the amniotic cells were chromatin-positive, while in the male fetus they were almost consistently chromatin-negative. In six male conceptions a low count (2 to 8%) of chromatin-positive nuclei were found, suggesting contamination of the amniotic fluid with maternal cells; the alternative possibility of sex chromosome mosaicism in the fetus is considered unlikely.
The fetal sex was also accurately predicted in the 13 cases examined by the quinacrine fluorescence methods for the fluorescent Y body (Y chromosome) in interphase nuclei. The low count of fluorescent bodies in B39, B61, and B71 is within the normal range (about 0-10%) of female somatic cell nuclei observed by ourselves (unpublished results) and others (Polani and Mutton, 1971) . In our experience with male somatic cell nuclei the normal range of fluorescent Y bodies is 30 to 80%.
Discussion
This study confirms that antenatal diagnosis has an important role in genetic counselling. Each of the patients was extremely anxious about the outcome of her pregnancy, but in every case this was alleviated by'antenatal diagnosis. As several patients had initially requested termination, the overall effect of amniocentesis has been to save pregnancies. The only pregnancy terminated was that of a carrier of fatal X-linked granulomatous disease where the fetus was found to be male with a 50% risk of being affected. Subsequently the fetus was found also to have Down's syndrome (trisomv G) The risk to a woman aged 37 years having an infant with Down's syndrome is about 1 in 262 (Carter and Evans, 1961) .
Few studies of genetic counselling based on antenatal diagnosis have been reported (Jacobson and Barter, 1967; Valenti and Kehaty, 1969; Fratantoni et al., 1969; Butler and Reiss, 1970; Gertner et al., 1970; Nadler and Gerbie, 1970; Gerbie BRITISH MEDICAL JOURNAL 9 OCTOBER 1971 . These studies are shown in Table IV (Hamerton, 1970) , in practice (Table IV) one-third of such conceptions had an unbalanced chromosome constitution.
In families who already have a child with Down's syndrome (trisomy G) there is an increased risk for recurrence of Down's syndrome (Carter and Evans, 1961) , but the finding of three affected fetuses in 69 mothers who had a previous trisomy G infant (Table IV) is much higher than expected. Antenatal diagnosis in patients over 40 years or with a previous child with Down's syndrome thus seems justified provided the risk to the mother and fetus is small (see below).
Two further indications for antenatal diagnosis are X-linked and autosomal recessive diseases. The management of mothers who are carriers of X-linked disorders depends on the sex of the fetus. The purpose of antenatal diagnosis is to distinguish the male fetus with a 50% risk of being affected from the unaffected female fetus. As only two X-linked disorders-the Hunter and the Lesch-Nyhan syndromes-at present can be specifically diagnosed in utero, it is expected that termination in this group will be high. This is confirmed in Table IV ; of 30 pregnancies to carrier mothers, 11 were terminated. Similarly, in autosomal recessive disorders in which the in utero diagnosis is possible by assay of the enzyme activity in cells cultured from amniotic fluid termination of 25 % affected homozygous fetuses is to be expected. Of 35 pregnancies studied nine were terminated because the fetus was affected (Table IV) .
Though amniocentesis caused little discomfort in our patients it is potentially dangerous and should be used only when there is a substantial risk of severe fetal abnormality. Among possible fetal complications are deaths from abruptio placentae, infection, fetal haemorrhage, and puncture of the fetus. Maternal complications may include maternal haemorrbage, peritonitis, rhesus isoimmunization, and premature labour. So far none of these complications have been observed in cases for genetic counselling. Gerbie et al. (1971) had no fetal or maternal complications attributable to the amniocentesis in their series of 238 pregnancies. They also have information In agreement with other studies (Nadler, 1968; Valenti and Kehaty, 1969; Abbo and Zellweger, 1970; Ferguson-Smith and Ferguson-Smith, 1970) one it was not known until 27 weeks. In the remaining two cases amniocentesis was delayed to 30 and 33 weeks by which time termination could not be contemplated (amniocentesis was performed because of matemal anxiety). As transabdominal amniocentesis is usually not practical before the 14th week of pregnancy, the optimal time for amniocentesis for antenatal diagnosis seems to be between 14 and 17 weeks' gestation. Though chromosome preparations made direct from the primary growth of amniotic cells on coverslips gave the quickest result, the number of mitoses in the initial analysis was in eight cases fewer than 10. Nevertheless, the quality of the mitoses was uniformly high, and a firm decision on the karyotype was possible on as few as four cells (B21). The probability of detecting chromosomal mosaicism is therefore low, but this eventuality can never be excluded even with the larger number of cells obtained later by subculture.
DETERMINATION OF SEX
The sex of the fetus was determined accurately by sex chromatin analysis in each of the 66 cases studied. Nelson and Emery (1970) (Borgaonkar and Hollander, 1971) .
Antenatal detection of genetic diseases by amniocentesis now perrrits a more practical approach to genetic counselling. The parents of a child with a genetic disease which has a high risk of recurrence in future offspring are often faced with th-e difficult decision of whether or not to risk another pregnancy. Antenatal diagnosis now offers such parents a real hope Should the test show an abnormal fetus, the medical geneticist can present the parents with the available alternatives. If the genetic disease is amenable to treatment, as in the case of congenital adrenal hyperplasia and galactosaemia, the in utero diagnosis will allow immediate treatment at birth. If no treatment is available, as with Down's syndrome and Duchenne muscular dystrophy, the parents can be offered a termination of pregnancy. Thus antenatal diagnosis now affords such parents the chance of having healthy children.
Undoubtedly, the number of genetic diseases detectable in itern will increase, narticularly in the group of inborn errors of metabolism. However, these disorders are too rare to permit routine screening, but in the chromosome disorders and X-linked diseases (which are numerically more important) se-reening of narticular at-risk gr-uns (Bobrow, 1971 B59, aged 38 and para 1+0, had a normal daughter, now 10 years old, by a previous marriage. She was initially referred for possible termination of pregnancy in view of her age and because her brother had Down's syndrome. B60, aged 40 and para 5 + 1, had four normal children and one miscarriage followed by a child with Down's syndrome. The amniotic cultures were lost by contamination with infected tissue culture medium and amniocentesis could not be repeated.
B62, aged 35 and para 1+0, had a daughter who died shortly after birth with Down's syndrome and congenital heart disease. For nine years she had avoided pregnancy because of the fear that another child might be similarly affected.
B65, aged 26 and para 3 + 0, had one stillbirth, the details of which were unknown, followed by two children with Down's syndrome (trisomy G). The patient and her husband had normal karyotypes without evidence of mosaicism in lymphocyte cultures (Bobrow, 1971) . B67, aged 26 and para 2 + 0, was heterozygous for a reciprocal translocation between the long arm of a group D chromosome and the short arm of a group B chromosome. Her father, her first child, and one of three sibs carried the same translocation. Her second child died seven months after birth with partial D trisomy due to the presence of the smaller of the two translocation chromosomes in addition to an otherwise normal female karyotype.
B68, aged 30 and para 3 + 0, had one stillbirth, a normal daughter, and a son who died two weeks after birth with multiple malformations including tracheo-oesphageal fistula and congenital heart disease. The parents both had normal karyotypes but the defective child was found to have an extra small acrocentric chromosome thought to represent a deleted D or E chromosome.
B70 aged 40 and para 2+0, had a normal daughter and a son who had severe mental retardation of unknown cause; his karyotype was normal. Amniocentesis was performed at 14 and again at 16 weeks as the first cultures failed.
B71, aged 39 and para 1+0. Her only child, who had Down's syndrome (trisomy G), died during the present pregnancy. A maternal half-cousin also had Down's syndrome. Amniocentesis was performed at 14 weeks' and at 16 weeks' gestation as the first cultures failed.
B72, aged 30 and para 2+0, had one son with mosaic Down's syndrome and another with pyloric stenosis. Both parents had normal karyotypes.
B73, aged 29 and para 1+0, had one normal daughter and a maternal first cousin once removed who had Down's syndrome (trisomy G and D/D translocation). Her husband had a maternal first cousin and a maternal first cousin once removed who had Down's syndrome.
B75, aged 41 and para 0, was referred for termination in early pregnancy because of acute anxiety about the risk of Down's syndrome with increasing maternal age. There was no family history of Down's syndrome.
B76, aged 46 and para 2+0, had children now aged 23 and 18 years. Her pregnancy was unplanned and she requested termination in view of her age.
